Evelyn Lillian Kachikwu, MD Surgery - Surgical Oncology Medicare: Accepting Medicare Assignments Practice Location: 1325 N Rose Dr, Ste 210, Placentia, CA 92870 Phone: 714-961-5804 Fax: 714-961-5809 |
Dr. Obaida Batal, MD Surgery Medicare: Medicare Enrolled Practice Location: 1041 E Yorba Linda Blvd Ste 209, Placentia, CA 92870 Phone: 714-823-3668 Fax: 714-844-9198 |
Robin R. Cole, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1325 N Rose Dr, Ste 202, Placentia, CA 92870 Phone: 714-203-1500 Fax: 714-203-1711 |
Richard Hal Stewardson, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1275 N Rose Dr, Ste 118, Placentia, CA 92870 Phone: 714-577-9090 Fax: 714-572-8483 |
News Archive
While most American adults may not be patently sick, a vast majority of them still lack full health and vitality. This state of "incomplete" health has resulted in a loss of productivity in the workforce, and potentially increases health care costs in the long term, according to a new Emory University study published in the May issue of the Journal of Environmental and Occupational Health.
Research conducted by Jason Middleton, PhD, Assistant Professor of Cell Biology and Anatomy, and Neuroscience at LSU Health New Orleans School of Medicine, and colleagues may lead to a treatment to prevent long-term sensory problems by restoring normal brain function in survivors of cardiac arrest.
Gene therapy could offer a new, long-lasting way to treat Parkinson's disease, research results announced Tuesday 15 July at FENS 2008 suggest. Dr Deniz Kirik of the University of Lund in Sweden has been using viruses to insert a new combination of genes into animals' brains, where they help produce the dopamine that is lacking in Parkinson's disease. The results suggest the treatment is very effective in animal models for several months, possibly years.
Chemists at the California Institute of Technology (Caltech) and The Scripps Research Institute (SRI) have developed an innovative technique to create cheap but highly stable chemicals that have the potential to take the place of the antibodies used in many standard medical diagnostic tests. James R. Heath, Ph.D., principal investigator of the Nanosystems Biology Cancer Center at Caltech, one of eight Centers of Cancer Nanotechnology Excellence, and K. Barry Sharpless, Ph.D., SRI, and their colleagues describe the new technique in the journal Angewandte Chemie International Edition.
Information about COVID-19 offered by the U.S. Centers for Disease Control and Prevention, the White House, and state health departments failed to meet recommendations for communicating with the public, according to a Dartmouth study.
› Verified 7 days ago